Login / Signup

Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease.

John D HeissAbhik Ray-ChaudhuryDavid E KleinerDebra J EhrlichGretchen ScottNancy A EdwardsDavid S GoldsteinDima A HammoudPiotr HadaczekVictor S Van LaarShantelle A GraffPeter HerscovitchCodrin LunguMark HallettRussell R LonserKareem A ZaghloulKrystof S Bankiewicz
Published in: Movement disorders : official journal of the Movement Disorder Society (2024)
F-FDOPA-PET signal, suggesting the regenerative potential of AAV2-GDNF in PD.
Keyphrases
  • gene therapy
  • stem cells
  • poor prognosis
  • mesenchymal stem cells
  • computed tomography
  • case report
  • low dose
  • cell therapy
  • pet ct
  • positron emission tomography
  • binding protein
  • pet imaging
  • human health
  • climate change